Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?
- PMID: 20359659
- DOI: 10.1016/S1470-2045(10)70035-8
Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?
Comment on
-
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Lancet Oncol. 2010. PMID: 19897418 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
